| LCZ696 InteMediate |
LCZ696中间体 |
1426129-50-1 |
| 4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester |
4-羟基-1-甲基-7-苯氧基-3-异喹啉羧酸甲酯 |
1421312-34-6 |
| 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro- |
AZD9291中间体3 |
1421372-67-9 |
| PFI-1 |
PFI-1 (PF-6405761) |
1403764-72-6 |
| 3-[2-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]-6-fluoro-1H-indole-4-carboxylic acid methyl ester |
3-[2-(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)乙基]-6-氟-1H-吲哚-4-羧酸甲酯 |
1408282-25-6 |
| RGFP 109 |
RG2833(RGFP109) |
1215493-56-3 |
| Oclacitinib |
奥拉替尼 |
1208319-26-9 |
| 1,3,5-Triazine, 2,4-diphenyl-6-(9,9'-spirobi[9H-fluoren]-2-yl)- |
2,4-二苯基-6-(9,9'-螺双[9H-芴]-2-基)-1,3,5-三嗪 |
1207176-84-8 |
| 4H-1-Benzothiopyran-4-one, 2,3-dihydro-2-[1-(phenylMethyl)-4-piperidinyl]- |
化合物Σ1 RECEPTOR ANTAGONIST-1 |
1204401-49-9 |
| DBCO-Acid |
11,12-二氢-Γ-氧代-二苯并[[F]偶氮-5-(6H)-丁酸 |
1353016-70-2 |
| MLN9708 |
艾沙佐米柠檬酸盐 |
1201902-80-8 |
| (E)-1-Ethoxyethene-2-ylboronic acid pinacol ester |
(E)-1-乙氧乙烯基-2-硼酸频那醇酯 |
1201905-61-4 |
| 5-Methyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)isoxazole |
5-甲基异噁唑-4-硼酸频哪醇酯 |
1346808-41-0 |
| HSF1A |
HSF1 ACTIVATOR;HSF1A;CAS 1196723-93-9 |
1196723-93-9 |
| 1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) |
1-(4-溴苯基)环丁胺盐酸盐 |
1193389-40-0 |
| NXL 104 |
阿维巴坦钠 |
1192491-61-4 |
| 1H-1,2,3-Triazole-1-acetic acid, 4-[[bis[[1-(1,1-diMethylethyl)-1H-1,2,3-triazol-4-yl]Methyl]aMino]Methyl]- |
BTTAA |
1334179-85-9 |
| DLin-KC2-DMA |
DLIN-KC2-DMA |
1190197-97-7 |
| N-(2-(diMethylaMino)ethyl)-1-(3-((4-((2-Methyl-1H-indol-5-yl)oxy)pyriMidin-2-yl)aMino)phenyl)MethanesulfonaMide |
5-羟基-2-甲基吲哚 |
1308672-74-3 |
| PF 4800567 hydrochloride |
无中文名称 |
1188296-52-7 |
QQ
微信
